Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer

研究成果: 雜誌貢獻文章同行評審

10 引文 斯高帕斯(Scopus)

指紋

深入研究「Targeted PARP Inhibition Combined with FGFR1 Blockade is Synthetically Lethal to Malignant Cells in Patients with Pancreatic Cancer」主題。共同形成了獨特的指紋。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science